A Unique Opportunity to gather....
.....Critical Drug Knowledge
Overview
- The future of post-marketing studies - still a matter of controversy ?
- From phase I through phase IV – strategies for improving quality
- Phase IV clinical studies – what are the expectations ?
- How can you sell the value of post-marketing studies to internal stakeholders ?